Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEGeneralMgmt Change1 Oct 2026

Finkurve Financial Services Ltd

Enclosed a copy of Outcome of Board Meeting held on October 1, 2026- Pursuant to Regulation 30 and 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Finkurve Financial Services Ltd has announced the change of Registrar & Transfer Agent (RTA) from MUFG to Purva, the resignation of Mr. Naveen Kottala as CEO, and the appointment of Mr. Siddharth Purandare as new CEO. The company has also approved the grant of 4,50,000 Employee Stock Options under the Finkurve ESOP Plan -2018.

Read more →📎 1 attachment
BSEGeneral▼ NegativeDebt Restruc.1 Oct 2026

Majestic Research Services and Solutions Ltd

Outcome of Board meeting held on October 1, 2026 - Intimation under Regulation 30 and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Majestic Research Services and Solutions Ltd has announced the outcome of its board meeting held on October 1, 2026, where it approved the cancellation and extinguishment of existing equity shares held by promoters and public shareholders, and the allotment of fresh equity shares to certain individuals.

Read more →📎 1 attachment
BSEGeneralFundraise1 Oct 2026

ACS Technologies Ltd

Outcome of Board Meeting

ACS Technologies Ltd has approved the allotment of 49,50,495 equity shares on a preferential basis to Adiniya Investments Private Limited at an issue price of INR 40.40 per share, increasing the company's paid-up equity share capital to INR 74,38,74,430.

Read more →📎 1 attachment
BSEGeneral1 Oct 2026

Tirupati Starch & Chemicals Ltd

To consider and approve the sale of immovable property of the Company situated at 181, Jaora Compound, Indore (MP) 452001 IN; To take note the completion of second consecutive term of 5 years of Mr. Ramesh Agrawal (DIN: 07599354), as an Independent Director of the Company with effect from end of the day of 30th September, 2026

Tirupati Starch & Chemicals Ltd has announced the sale of its immovable property at 181, Jaora Compound, Indore, and the completion of Mr. Ramesh Agrawal's second consecutive term as an Independent Director.

Read more →📎 1 attachment
BSEGeneralRegulatory1 Oct 2026

Schneider Electric Infrastructure Ltd

Regarding news clarification on Schneider Electric, NFH join hands to explore digital energy grid applications and movement in price on Oct 1, 2026, we wish to clarify that the news pertains to another entity within Schneider group and the Company is fully conscious of its obligations under applicable laws. Enclosed herewith detailed clarification.

Schneider Electric Infrastructure Ltd clarifies that news about Schneider Electric and NFH joining hands to explore digital energy grid applications pertains to another entity within the Schneider Group, not the company itself.

Read more →📎 1 attachment
BSEGeneralExpansion1 Oct 2026

Gland Pharma Ltd

Outcome of Board Meeting held on October 01, 2026

Gland Pharma Ltd has announced the outcome of its board meeting held on October 01, 2026. The board has approved an investment of USD 21 million in Gland Pharma USA Inc., a wholly-owned subsidiary, to subscribe to 60% of the equity share capital of Novelstar Pharma Inc. Additionally, Mr. Wenjie Zhang has resigned as a Non-Executive & Non-Independent Director, and Mr. Xingli Wang has been appointed as an Additional Director. The committees of the board have been realigned in compliance with the Listing Regulations.

Read more →📎 1 attachment